CSRxP: SENATE JUDICIARY COMMITTEE SHOULD REJECT PHARMA-SUPPORTED POLICIES THAT WOULD UNDERMINE BIPARTISAN PROGRESS ON PATENT ABUSE
Lawmakers Should Remain Focused on Holding Big Pharma Accountable for… Read More
Lawmakers Should Remain Focused on Holding Big Pharma Accountable for… Read More
Legislation Scheduled for Thursday Markup Would Encourage Adoption of… Read More
HELP Committee Hearing an Opportunity to Highlight Staggering Cost… Read More
Brand Name Drug Companies Applying Price-Hiking, Patent Abuse Playbook to… Read More
Lawmakers Should Focus on Holding Big Pharma Accountable for Egregious Pricing… Read More
Letter Encourages Lawmakers to Advance Bipartisan Solutions to Hold Big Pharma… Read More
Campaign Will Add Support to Growing Bipartisan Momentum to Crack Down on Big… Read More
New Report Emphasizes The “Pharmaceutical Industry’s Patent Gamesmanship… Read More
Lowering Prices for Some Patients at Some Dosages Will Have Limited Impact,… Read More
Price Hikes and Egregious Prices on Blockbuster Drugs Boost Profits… Read More
Analysis Finds GLP-1 Blockbusters and “Multimillion-Dollar Gene Therapies”… Read More
Big Pharma Continues Raking in Expectation-Beating Profits and Revenue Fueled… Read More